Tethered‐liquid omniphobic surface coating reduces surface thrombogenicity, delays clot formation and decreases clot strength ex vivo

Abstract

Hemocompatible materials for extracorporeal life support (ECLS) technology are investigated to mitigate thrombotic complications associated with this therapy. A promising solution is an omniphobic bilayer coating, tethered liquid perfluorocarbon (TLP), which utilizes an immobilized tether to anchor a mobile, liquid surface lubricant that prevents adhesion of blood components to the substrate. In this study, we investigated the effects of TLP on real‐time clot formation using thromboelastography (TEG). TLP was applied to TEG cups, utilizing perfluorodecalin (PFD) or FluorLube63 as the liquid layer, and compared to uncoated cups. Human blood (n = 10) was added to cups; and TEG parameters (R, K, α‐angle, MA, LY30, LY60) and adherent thrombus weight were assessed. TLP decreased clot amplification (α‐angle), clot strength (MA), and adherent clot weight (p p p = .0019; clot weight p p = .0377). Percent fibrinolysis (LY30 and LY60) was greater in the TLP versus controls at LY30 (p p = .0021). TLP significantly altered clot formation, exerting antithrombogenic effects. This reduction in surface thrombogenicity supports TLP as a candidate for improved biocompatibility of ECLS materials, pending further validation with exposure to shear stress.

Document Details

Document Type
Pub Defense Publication
Publication Date
May 08, 2019
Source ID
10.1002/jbm.b.34406

Entities

People

  • Andrew P Cap
  • Andriy I. Batchinsky
  • Daniel C. Leslie
  • Leopoldo C. Cancio
  • Teryn R. Roberts

Organizations

  • Geneva Foundation
  • United States Army Institute of Surgical Research
  • United States Army Medical Research and Development Command
  • University of South Florida
  • University of the Incarnate Word

Tags

Readers

  • Neurological Diseases/Conditions/Disorders
  • Surface Coatings Technology.
  • Trauma Surgery or Emergency Medicine.